Jefferies Assumes Coverage of Avanir Pharmaceuticals

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Jefferies is assuming coverage of Avanir Pharmaceuticals (NASDAQ: AVNR) with a $3.50 price target and a Hold rating.“AVNR markets Nuedexta, a low-dose combination of dextromethorphan and quinidine, for pseudobulbar affect, a disorder of laughing or crying that can accompany neurological disease,” Jefferies writes. “While the market is large, initial sales have been slow and signal significant physician and patient education is needed.”Avanir Pharmaceuticals closed Thursday at $4.50.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!